Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

NSF Grant Program to Advance Nano-Biosensing

by Global Biodefense Staff
August 10, 2015

The National Science Foundation Nano-Biosensing program supports fundamental engineering research on devices and methods for measurement and quantification of biological analytes.

The program is offering grants for research and development to advance the state-of-the-art in nano-biosensing. Stated areas of interest include:

  • Improved multi-purpose sensor platforms
  • Novel transduction mechanisms and sensor designs
  • Error-free detection of pathogens and toxins in food matrices, waterborne pathogens, parasites, toxins, and biomarkers in body fluids
  • Highly selective bio-recognition elements which exhibit zero false negative responses.
  • Nano-biosensors that enable measurement of kinetics and thermodynamics of biomolecular interactions in their native states, transmembrane transport, intracellular transport, and other biological phenomena
  • Fundamental studies on surface functionalization and immobilization of bio-recognition molecules, orientation, activity, stability and effectiveness at biosensor interfaces

NSF stated that this grant program does not support applications with incremental improvements of existing approaches and technologies.  Projects that do not include experimental characterization of sensor responses to biological analytes are also discouraged.

Further details on the grant program are available via Solicitation Number: PD-15-7909. The deadline for applications is October 20, 2015.

Tags: BiomarkersNanotechPOC DiagnosticsRequest for Proposals

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC